Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases

Volume:10   Issue:7
Pp: 649-659
M. Salerno, E. Cenni, C. Fotia, S. Avnet, D. Granchi, F. Castelli, D. Micieli, R. Pignatello, M. Capulli, N. Rucci, A. Angelucci, A. Del Fattore, A. Teti, N. Zini, A. Giunti and N. Baldini
DOI: 10.2174/156800910793605767

Oxaliplatin-mediated Inhibition of Survivin Increases Sensitivity of Head and Neck Squamous Cell Carcinoma Cell Lines to Paclitaxel

Volume:10   Issue:7
Pp: 660-669
Z. Khan, N. Khan, A. K. Varma, R. P. Tiwari, S. Mouhamad, G. B.K.S. Prasad and P. S. Bisen
DOI: 10.2174/156800910793605866

Is Src a Viable Target for Treating Solid Tumours?

Volume:10   Issue:7
Pp: 683-694
B. Elsberger, B. Stewart, O. Tatarov and J. Edwards
DOI: 10.2174/156800910793605802

Modular Branched Neurotensin Peptides for Tumor Target Tracing and Receptor-Mediated Therapy: A Proof-of-Concept

Volume:10   Issue:7
Pp: 695-704
C. Falciani, B. Lelli, J. Brunetti, S. Pileri, A. Cappelli, A. Pini, C. Pagliuca, N. Ravenni, L. Bencini, S. Menichetti, R. Moretti, M. De Prizio, M. Scatizzi and L. Bracci
DOI: 10.2174/156800910793605875

Wnt/β-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

Volume:10   Issue:7
Pp: 716-727
R. K. Gandhirajan, S. J. Poll-Wolbeck, I. Gehrke and K.-A. Kreuzer
DOI: 10.2174/156800910793605794

New Insights of CTLA-4 into Its Biological Function in Breast Cancer

Volume:10   Issue:7
Pp: 728-736
H. Mao, L. Zhang, Y. Yang, W. Zuo, Y. Bi, W. Gao, B. Deng, J. Sun, Q. Shao and X. Qu
DOI: 10.2174/156800910793605811

Dynamic Simulations of Pathways Downstream of ERBB-Family, Including Mutations and Treatments: Concordance with Experimental Results

Volume:10   Issue:7
Pp: 737-757
N. Castagnino, L. Tortolina, A. Balbi, R. Pesenti, R. Montagna, A. Ballestrero, D. Soncini, E. Moran, A. Nencioni and S. Parodi
DOI: 10.2174/156800910793605848

DNA Topoisomerase II Enzymes as Molecular Targets for Cancer Chemotherapy

Volume:10   Issue:7
Pp: 758-771
K. Chikamori, A. G. Grozav, T. Kozuki, D. Grabowski, R. Ganapathi and M. K. Ganapathi
DOI: 10.2174/156800910793605785

Concomitant CXCR4 and CXCR7 Expression Predicts Poor Prognosis in Renal Cancer

Volume:10   Issue:7
Pp: 772-781
C. D'Alterio, C. Consales, M. Polimeno, R. Franco, L. Cindolo, L. Portella, M. Cioffi, R. Calemma, L. Marra, L. Claudio, S. Perdona, S. Pignata, G. Facchini, G. Carteni, N. Longo, L. Pucci, A. Ottaiano, S. Costantini, G. Castello and S. Scala
DOI: 10.2174/156800910793605839

Cancer Therapy By Targeting Hypoxia-Inducible Factor-1

Volume:10   Issue:7
Pp: 782-796
Y. Li and D. Ye
DOI: 10.2174/156800910793605857